Thrombectomy Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Thrombectomy Devices Market By Product Type (Aspiration Thrombectomy devices, Rheolytic Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices), By Application (Peripheral Vascular, Neurovascular, Cardiovascular, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASC’s), Others) and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Thrombectomy Devices Market size was valued at USD 1,682.07 million in 2021, growing at a CAGR of 5.8% during the forecast period 2022-2028. A surgical thrombectomy occurs when a blood clot is removed from a vein or artery. Surgery is performed when blood coagulates and clusters in the blood vessels, forming a blood clot. During surgery, thrombectomy instruments are used to make an incision in a blood vessel. Blood flow is restored once the clot is removed and the blood artery is healed. Thrombectomy devices are the most widely used for thrombectomy treatments when compared to other methods. Increasing prevalence of CVDs and neurological illnesses, technological advancements, government initiatives aimed at disease prevention, and favourable medical reimbursement situations are all driving the Thrombectomy Devices market in healthcare forward. Thrombectomy systems are used in a number of therapies where clots must be removed in order to provide effective treatment and preserve patients’ lives. Acute myocardial infarction (AMI), peripheral arterial disease (PAD), deep vein thrombosis (DVT), pulmonary embolism (PE), and neurovascular operations can all benefit from the thrombectomy system’s versatility. In addition, the market share is predicted to grow due to an increase in demand for less invasive surgeries and an ageing population. Furthermore, the rising frequency of cardiac disorders, combined with changing lifestyles, is likely to propel the market forward.

Key Development:

In Oct 2015, Penumbra, Inc. has launched Separator 3D, an advanced thrombectomy device to treat cerebral occlusions that causes ischemic stroke

Thrombectomy Devices Market

MARKET SUMMARY
-
5.8%
  • Study Period– 2022 – 2028
  • Base Year– 2022
  • CAGR– 5.8%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Thrombectomy Devices Market

  • The report on global thrombectomy devices market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, by end user and geography.
  • thrombectomy devices market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Argon Medical Devices, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Terumo Corporation (Japan)
  • Spectranetics Corporation (U.S.)
  • Teleflex Incorporated (U.S.)
Thrombectomy Devices Market Dynamics

The market is expected to be driven by an increase in the senior population as a result of increased life expectancy, modern lifestyle, and disposable money. Life expectancy has increased as a result of medical improvements. As a result, the geriatric population is on the rise. This population segment is predisposed to cardiovascular and other disorders, making it a market driver. People are known to experience a lot of stress as a result of their modern lifestyle. This can increase the risk of heart attacks and other cardiovascular illnesses.


North-America Got Significant Share

Thrombectomy Devices Market

North America thrombectomy devices market is anticipated have significant growth rate due to increase in prevalence of cardiovascular diseases and presence of the key market players. Asia Pacific thrombectomy devices market is expected to have the lucrative growth opportunity owing to developing healthcare infrastructure, prevalence of the cardiovascular diseases and growing awareness & demand for the minimally invasive surgeries.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Thrombectomy Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

Description

Thrombectomy Devices Market size was valued at USD 1,682.07 million in 2021, growing at a CAGR of 5.8% during the forecast period 2022-2028. A surgical thrombectomy occurs when a blood clot is removed from a vein or artery. Surgery is performed when blood coagulates and clusters in the blood vessels, forming a blood clot. During surgery, thrombectomy instruments are used to make an incision in a blood vessel. Blood flow is restored once the clot is removed and the blood artery is healed. Thrombectomy devices are the most widely used for thrombectomy treatments when compared to other methods. Increasing prevalence of CVDs and neurological illnesses, technological advancements, government initiatives aimed at disease prevention, and favourable medical reimbursement situations are all driving the Thrombectomy Devices market in healthcare forward. Thrombectomy systems are used in a number of therapies where clots must be removed in order to provide effective treatment and preserve patients’ lives. Acute myocardial infarction (AMI), peripheral arterial disease (PAD), deep vein thrombosis (DVT), pulmonary embolism (PE), and neurovascular operations can all benefit from the thrombectomy system’s versatility. In addition, the market share is predicted to grow due to an increase in demand for less invasive surgeries and an ageing population. Furthermore, the rising frequency of cardiac disorders, combined with changing lifestyles, is likely to propel the market forward.

Key Development:

In Oct 2015, Penumbra, Inc. has launched Separator 3D, an advanced thrombectomy device to treat cerebral occlusions that causes ischemic stroke

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX